---
figid: PMC7072930__ijms-21-01340-g002
figtitle: Therapy for fibrodysplasia ossificans progressive (FOP)
organisms:
- NA
pmcid: PMC7072930
filename: ijms-21-01340-g002.jpg
figlink: pmc/articles/PMC7072930/figure/ijms-21-01340-f002/
number: F2
caption: Potential therapy for fibrodysplasia ossificans progressive (FOP). A gain-of-function
  mutation of ACVR1 (mutACVR1) induces ENPP2 expression by activating the Smad pathway.
  Activin A functions as a ligand of the mutant ACRV1. Secreted ENPP2 stimulates mTOR
  signaling, consequently causing FOP. mTOR signaling suppresses the effect of mutant
  ACRV1.
papertitle: Role of Signal Transduction Pathways and Transcription Factors in Cartilage
  and Joint Diseases.
reftext: Riko Nishimura, et al. Int J Mol Sci. 2020 Feb;21(4):1340.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9518552
figid_alias: PMC7072930__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7072930__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7072930__ijms-21-01340-g002.html
  '@type': Dataset
  description: Potential therapy for fibrodysplasia ossificans progressive (FOP).
    A gain-of-function mutation of ACVR1 (mutACVR1) induces ENPP2 expression by activating
    the Smad pathway. Activin A functions as a ligand of the mutant ACRV1. Secreted
    ENPP2 stimulates mTOR signaling, consequently causing FOP. mTOR signaling suppresses
    the effect of mutant ACRV1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - INHBA
  - INHBB
  - ENPP2
  - MTOR
  - SMAD4
  - SMAD5
  - SMAD1
  - GARS1
  - ACVR1
  - CEP43
  - CHTOP
---
